Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices.

Echt, D S; Gremillion, S T; Lee, J T; Roden, D M; Murray, K T; Borganelli, M; Crawford, D M; Stewart, J R; Hammon, J W

Echt, D S; Gremillion, S T; Lee, J T; Roden, D M; Murray, K T; Borganelli, M; Crawford, D M; Stewart, J R; Hammon, J W.

Affiliation

Echt DS; Division of Cardiology, Vanderbilt University, Nashville, Tennessee.

J Cardiovasc Electrophysiol ; 5(9): 752-60, 1994 Sep.

Article in En | MEDLINE | ID: mdl-7827714

Subject(s)

Arrhythmias, Cardiac/therapy; Defibrillators, Implantable; Lidocaine/therapeutic use; Procainamide/therapeutic use; Aged; Combined Modality Therapy; Electrocardiography; Female; Humans; Male; Middle Aged; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arrhythmias, Cardiac / Procainamide / Defibrillators, Implantable / Lidocaine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Cardiovasc Electrophysiol Journal subject: ANGIOLOGIA / CARDIOLOGIA / FISIOLOGIA Year: 1994 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links